Navigation Links
Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
Date:9/13/2007

Two-Day Multiplexing Technology Symposium Brings Together Thought Leaders in Life Sciences and Clinical Diagnostics to Share Ideas and Best Practices

OOSTERHOUT, Netherlands, Sept. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the world leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2007, the company's annual European end-user technology symposium. The two-day event will be held 2-3 October at the Berlage's Exchange in Amsterdam, the Netherlands, and will feature a range of presentations regarding Luminex's flexible xMAP(R) multiplexing technology in clinical diagnostics and life science research applications.

"We are thrilled to welcome xMAP technology end-users back to The Netherlands for our fifth annual Planet xMAP Europe," said Paul C. Ladestein, Director of European Operations for Luminex. "This event will allow scientists, researchers and clinicians to come together to share best practices and ideas not only about xMAP technology, but about the broader role that multiplexing technology is playing to improve research and enhance the quality of patient care."

Planet xMAP Europe 2007 will feature two days of presentations and workshops. Day One, Tuesday, 2 October, will concentrate on xMAP-based clinical diagnostics applications and include the following presentations:

-- Dr. John C. Carrano, Vice President, Research and Development Luminex Corporation (USA) - "xMAPing the Future: A Vision of Innovative Products and Dominant Solutions"

-- Dr. Susan J. Wong, Diagnostic Immunology Laboratory, Wadsworth Center NYSDOH (USA) - "Comparison of AtheNA Multi-Lyte Bb Microsphere Immunoassay to Two-Tier Serology for Laboratory Confirmation of Lyme Disease"

-- Dr. Mario J. Marcon, Director of Clinical/Molecular Microbiology, Virology, & Immunoserology, Department of Laboratory Medicine Children's Hospital, Columbus, OH (USA) - "Evaluation of the Plexus Epstein Barr Virus Panels in a children's Hospital Setting"

-- Professor Kai Zacharowski, M.D., Ph.D., Chair of Cardiovascular Anesthesia & Critical Care, Bristol Royal Infirmary (United Kingdom) - "Cytokines - From Head to Toe"

-- Dr. Diana Pauly, Center for Biological Safety, Microbial Toxins, Robert Koch-Institute (Germany) - "Simultaneous Detection of Bacterial and Plant Toxins Using a Multiplex Magnetic Bead Assay"

-- Dr. Gary T. Brice, United States Navy Medical Research Unit, Department of Immunology (Indonesia) - "Etiology of Respiratory Viral Pathogens in Suspect H5N1 Samples in Indonesia"

Day Two of Planet xMAP Europe 2007, Wednesday, 3 October, will focus on xMAP-based life science research applications and feature the following presentations:

-- Dr. Marion Lanteri, Postdoctoral Fellow, Immunology - "Cytokine Signature of Early Viral Infections"

-- Professor Thomas Herget, Ph.D., Director PLS R&D/New Technology Evaluation, Merck KGaA (Germany) - "Safety Biomarkers: Holy Grail of Toxicology"

-- Dr. Jochen Schwenk, KTH - Royal Institute of Technology, Alba Nova University Center, Department of Proteomics (Sweden) - "Multiplexed Approaches within Antibody Proteomics"

-- Dr. Corrado M. Cilio, Cellular Autoimmunity Unit, Department of Clinical Sciences and Pediatrics, Malmo University Hospital (Sweden) - "MicroRNA"

-- Dr. Oliver Poetz, NMI, Natural and Medical Science Institute at the University of Tuebingen (Germany) - "Magnetic Beads Work Better at Night"

-- Dr. Ben van Ommen, TNO Quality Life (The Netherlands), Head of Nutrigenomics and Nutritional Systems Biology Activities - "The Targeted Plasma Proteome in Personalized Health and Nutrition"

For additional information on Planet xMAP Europe 2007 or to register, please visit http://www.planetxmap.com or contact Jenny Busch (+31-162-408333 (332) or xmapeurope@luminexcorp.com).

About Luminex

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP(R) multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at http://www.luminexcorp.com.

Luminex Corporate Contact:

Harriss T. Currie

Vice President, Finance and Chief Financial Officer

512-219-8020

Luminex Media Contact:

Nicole Cottrill

327-327-7999


'/>"/>
SOURCE Luminex Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Bacterial RNA Isolation From Infected Eukaryotic Hosts
11. Bacterial RNA Isolation From Infected Eukaryotic Hosts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Liquid Biopsy System , a fully automated benchtop system for collecting intact circulating ... is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... the Life -Sciences division, Treximo will pair its $200M operational capacity with ... consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... -- Lexus, a returning partner of the Amgen Tour of California ... partner of the men,s and women,s events for the next five ... Tour of California will mark the start ... professional cycling teams in the world racing from Northern to ... Breakaway from Heart Disease TM Women,s Race empowered with ...
(Date:2/21/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Bioplastics & Biopolymers ... over the next decade to reach approximately $8.9 billion by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology Technology:
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):